Recent research has shown that C29 markedly decreases the expression of inflammatory markers, including IL-6 and TNF-α, through the inhibition of the TLR2/NF-κB/COX-2 signaling pathway, which helps relieve traumatic deep vein thrombosis (135). This evidence concerns the gene TLR2 and deep vein thrombosis.